Delivery Order SPE2DB24D2205-SPE2DB24FDZYJ
Award Date
9/16/24
Potential Completion Date
10/7/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug VYNDAQEL 20 MG CAPSULE UD 120S. The contract has a ceiling value of $12,960.30 and is a delivery order with a firm-fixed price structure. The contract has an ultimate completion date of October 3, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor for this award, which is not designated...
This federal contract award, valued at $18,157.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has a completion date of November 18, 2024 and was awarded on October 25, 2024. The award is not designated as a set-aside contract. In addition to this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.23 firm fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $12,960.30, is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product, with a completion date of June 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $13,408.24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product VYNDAQEL 20 MG CAPSULE UD 120S. This is a firm fixed-price delivery order contract with a completion date of December 19, 2024. The contract was awarded on November 27, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $18,784.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,960.30 firm fixed price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The order has an ultimate completion date of August 1, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $12,960.30 firm fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, with a completion date of June 20, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,196,981 units of the pharmaceutical product VYNDAQEL 20 MG CAPSULE UD 120S. The $12,345.34 contract has a completion date of January 22, 2024. No set-aside designation was used. AmerisourceBergen Drug Corp is a prime contractor that provides pharmaceutical products and distribution services to...
This is a $12,960.30 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is to provide 4,565,455,900 units of the pharmaceutical product VYNDAQEL 20 MG CAPSULE UD 120S. There is no set-aside designation for this award. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC...